Skip to main content

Advertisement

SpringerLink
Log in

Does the Extent of Resection Impact Survival for Duodenal Adenocarcinoma? Analysis of 1,611 Cases

  • Gastrointestinal Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Because duodenal adenocarcinoma (DA) is relatively rare, few studies have investigated the impact of resection type on long-term outcomes.

Methods

The Surveillance, Epidemiology, and End Results database was used to identify all patients between 1988 and 2010 with DA. Patients were divided into two groups based on the type of surgery received: simple resection (SR), defined as a simple removal of the primary site, and radical resection (RR), defined as removal of the primary site with a resection in continuity with other organs. Differences in disease-specific survival (DSS) and overall survival (OS) were compared.

Results

Of the 1,611 patients included, 746 (46.3 %) underwent SR and 865 (53.7 %) underwent RR. As expected, patients undergoing RR were more likely to present with poorly differentiated and large tumors, as well as advanced stage disease. Despite greater lymph node (LN) retrieval (11.0 vs. 6.8; p < 0.0001), RR was not associated with improved survival (5-year DSS and OS rates of 52.8 and 41.3 % for SR vs. 48.8 and 37.6 % for RR; p > 0.05). On univariate Cox proportional hazards regression analysis, the type of surgery was not associated with OS (odds ratio [OR] 0.98; 95 % confidence interval [CI] 0.87–1.11). Increasing TNM stages, tumor grade, fewer LNs removed, LN ratio, and absence of radiation were associated with worse survival. After controlling for confounding factors, type of surgery still did not influence OS (OR 1.11; 95 % CI 0.97–1.27).

Conclusions

Radical resection (e.g., in the form of pancreaticoduodenectomy) does not appear to impact survival compared with simple segmental resection for DA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Overman MJ, Hu C-Y, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer. 2010;116(23):5374–82. doi:10.1002/cncr.25324.

    Article  PubMed  Google Scholar 

  2. Overman MJ, Hu C-Y, Kopetz S, Abbruzzese JL, Wolff RA, Chang GJ. A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease. Ann Surg Oncol. 2012;19(5):1439–45. doi:10.1245/s10434-011-2173-6.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Moss WM, McCart PM, Juler G, Miller DR. Primary adenocarcinoma of the duodenum. Arch Surg. 1974;108(6):805–7.

    Article  CAS  PubMed  Google Scholar 

  4. Cortese AF, Cornell GN. Carcinoma of the duodenum. Cancer. 1972;29(4):1010–5.

    Article  CAS  PubMed  Google Scholar 

  5. Ouriel K, Adams JT. Adenocarcinoma of the small intestine. Am J Surg. 1984;147(1):66–71.

    Article  CAS  PubMed  Google Scholar 

  6. Sohn TA, Lillemoe KD, Cameron JL, et al. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg Off J Soc Surg Aliment Tract. 1998;2(1):79–87.

    Article  CAS  Google Scholar 

  7. Barnes G Jr, Romero L, Hess KR, Curley SA. Primary adenocarcinoma of the duodenum: management and survival in 67 patients. Ann Surg Oncol. 1994;1(1):73–8.

    Article  PubMed  Google Scholar 

  8. Joesting DR, Beart RW Jr, van Heerden JA, Weiland LH. Improving survival in adenocarcinoma of the duodenum. Am J Surg. 1981;141(2):228–31.

    Article  CAS  PubMed  Google Scholar 

  9. Lowell JA, Rossi RL, Munson JL, Braasch JW. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection. Arch Surg. 1992;127(5):557–60.

  10. Kaklamanos IG, Bathe OF, Franceschi D, Camarda C, Levi J, Livingstone AS. Extent of resection in the management of duodenal adenocarcinoma. Am J Surg. 2000;179(1):37–41.

    Article  CAS  PubMed  Google Scholar 

  11. Bakaeen FG, Murr MM, Sarr MG, et al. What prognostic factors are important in duodenal adenocarcinoma? Arch Surg. 2000;135(6):635–41; discussion 641–42.

  12. Brenner RL, Brown CH. Primary carcinoma of the duodenum; report of 15 cases. Gastroenterology. 1955;29(2):189–98.

    CAS  PubMed  Google Scholar 

  13. Berger L, Koppelman H. Primary carcinoma of the duodenum. Ann Surg. 1942;116(5):738–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Newton WT. Mortality and morbidity associated with resection of pancreaticoduodenal cancers. Am Surg. 1961;27:74–9.

    CAS  PubMed  Google Scholar 

  15. Stewart HL, Lieber MM. Carcinoma of the suprapapillary portion of the duodenum. Arch Surg. 1937;35(1):99–129. doi:10.1001/archsurg.1937.01190130102005.

    Article  Google Scholar 

  16. Rose DM, Hochwald SN, Klimstra DS, Brennan MF. Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg. 1996;183(2):89–96.

    CAS  PubMed  Google Scholar 

  17. Van Ooijen B, Kalsbeek HL. Carcinoma of the duodenum. Surg Gynecol Obstet. 1988;166(4):343–7.

    PubMed  Google Scholar 

  18. Tocchi A, Mazzoni G, Puma F, et al. Adenocarcinoma of the third and fourth portions of the duodenum: results of surgical treatment. Arch Surg. 2003;138(1):80–5.

  19. Hu J-X, Miao X-Y, Zhong D-W, Dai W-D, Liu W, Hu W. Surgical treatment of primary duodenal adenocarcinoma. Hepatogastroenterology. 2006;53(72):858–62.

    PubMed  Google Scholar 

  20. Sarela AI, Brennan MF, Karpeh MS, Klimstra D, Conlon KCP. Adenocarcinoma of the duodenum: importance of accurate lymph node staging and similarity in outcome to gastric cancer. Ann Surg Oncol. 2004;11(4):380–6. doi:10.1245/ASO.2004.05.021.

    Article  PubMed  Google Scholar 

  21. Gibbs JF. Duodenal adenocarcinoma: is total lymph node sampling predictive of outcome? Ann Surg Oncol. 2004;11(4):354–5. 10.1245/ASO.2004.02.914.

    Article  PubMed  Google Scholar 

  22. Lee HG, You DD, Paik KY, Heo JS, Choi SH, Choi DW. Prognostic factors for primary duodenal adenocarcinoma. World J Surg. 2008;32(10):2246–52. doi:10.1007/s00268-008-9678-6

    Article  PubMed  Google Scholar 

  23. Sexe RB, Wade TP, Virgo KS, Johnson FE. Incidence and treatment of periampullary duodenal cancer in the U.S. veteran patient population. Cancer. 1996;77(2):251–4. doi:10.1002/(SICI)1097-0142(19960115)77:2<251::AID-CNCR5>3.0.CO;2-P.

    Article  CAS  PubMed  Google Scholar 

  24. Poultsides GA, Huang LC, Cameron JL, et al. Duodenal adenocarcinoma: clinicopathologic analysis and implications for treatment. Ann Surg Oncol. 2012;19(6):1928–35. doi:10.1245/s10434-011-2168-3.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Liang T-J, Wang B-W, Liu S-I, et al. Number of involved lymph nodes is important in the prediction of prognosis for primary duodenal adenocarcinoma. J Chin Med Assoc JCMA. 2012;75(11):573–580. doi:10.1016/j.jcma.2012.08.002.

    Article  Google Scholar 

  26. Delcore R, Thomas JH, Forster J, Hermreck AS. Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg. 1993;166(6):626–31. doi:10.1016/S0002-9610(05)80668-3.

    Article  CAS  PubMed  Google Scholar 

  27. Struck A, Howard T, Chiorean EG, Clarke JM, Riffenburgh R, Cardenes HR. Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival. J Surg Oncol. 2009;100(2):144–8. doi:10.1002/jso.21319.

    Article  PubMed  Google Scholar 

  28. Kelsey CR, Nelson JW, Willett CG, et al. Duodenal adenocarcinoma: patterns of failure after resection and the role of chemoradiotherapy. Int J Radiat Oncol. 2007;69(5):1436–41. doi:10.1016/j.ijrobp.2007.05.006.

    Article  Google Scholar 

  29. Swartz MJ, Hughes MA, Frassica DA, et al. ADjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum. Arch Surg. 2007;142(3):285–8. doi:10.1001/archsurg.142.3.285.

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

  1. Department of Surgery, Stanford University, Stanford, CA, USA

    Jordan M. Cloyd MD, Jeffrey A. Norton MD, Brendan C. Visser MD & George A. Poultsides MD

Authors
  1. Jordan M. Cloyd MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey A. Norton MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brendan C. Visser MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George A. Poultsides MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to George A. Poultsides MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cloyd, J.M., Norton, J.A., Visser, B.C. et al. Does the Extent of Resection Impact Survival for Duodenal Adenocarcinoma? Analysis of 1,611 Cases. Ann Surg Oncol 22, 573–580 (2015). https://doi.org/10.1245/s10434-014-4020-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-014-4020-z

Keywords

Search

Navigation